• This Reanimated Heart Footage Is Amazing

    The reanimation allows for visualization of the unique functional anatomies within each heart, explains the University of Minnesota's Paul Iaizzo. Chris Newmarker This living pig heart is hooked up on equipment to keep it beating at the University of Minnesota's Visible Heart Lab. Such equipment has also been used to reanimate 70 human hearts over the past 17 years. (Image courtesy of Visible Heart Lab)Watch enough Frankenstein movies, and you'll probably get excited about the idea of...
  • Theranos CEO Can't Catch a Break

    CEO Elizabeth Holmes has stepped down as an entrepreneurial ambassador for the Obama administration.Chris NewmarkerTheranos CEO Elizabeth Holmes and Vice President Joe Biden spoke on the importance of preventive medicine at a press event last year at the compamy's Newark, CA lab, which later ran afoul of CMS. (Image courtesy of Theranos)When will things ever get better for Theranos CEO Elizabeth Holmes? Her company acknowledged Wednesday that she was stepping down as an...
  • Medtech's Top Young Innovators

    They’re behind innovations in mobile health, diagnostics, exoskeletons, and much more. Meet the medical technology field’s rising stars.Qmed StaffOmron Blauo, 25, started Telescrypts because he wanted people in developing countries to have access to wearable healthcare technology that was both quality but inexpensive. Samantha Huynh, 27, is designing an exoskeleton that reads the wearer's own muscle signals. She's a biomedical engineering PhD student at the University of Southern...
  • 3-D Bioprinting Is Heading to Space

    Russia’s space program reportedly wants to get a magnetic, zero-gravity, 3-D bioprinter onboard the International Space Station by 2018.Chris NewmarkerRussia's state-run United Rocket and Space Corp. (Roscosmos) has inked a deal with a company called 3D Bioprinting Solutions to create a bioprinter able to operate in the weightless environment of space. 9 Eye-Opening Facts about NASA's Medical TechnologyThe goal is to have a bioprinter ready for delivery to the International...
  • Was Theranos CEO Smart to Speak at Conference?

    Elizabeth Holmes reportedly continued to deflect blame during her appearance at a Philadelphia conference, and she had a tough time with CNN’s Sanjay Gupta, too. Chris NewmarkerTheranos CEO Elizabeth Holmes is attempting to turn a corner with her troubled Silicon Valley blood testing company: more data, more public appearances, more interviews. It has also resulted in more trouble, apparently. In a Monday appearance at the American Association for Clinical Chemistry annual...
  • IBM Touts Lab-on-a-Chip Breakthrough

    The high tech giant’s scientists say the technology is able to separate biological particles at the nanoscale. Chris NewmarkerA new lab-on-a-chip developed at IBM could potentially allow physicians to detect diseases such as cancer before symptoms appear, the high tech giant announced this week. Tests of the chip, reported in the journal Nature Nanotechnology, show the chip separating biological particles at the nanoscale level. Separation of bioparticles took place down to the scale...
  • Gore's Highly Flexible Vascular Stent Wins FDA Approval

    The third-generation stent is designed for high conformability, making it ideal for peripheral artery disease cases in more complex anatomies.Marie ThibaultW.L. Gore & Associates announced on Tuesday that its TIGRIS Vascular Stent has earned FDA approval. The stent, used to treat peripheral artery disease (PAD), had a zero fracture rate in its U.S. clinical study. This means it is well-suited to withstand the flexion, torsion, compression, and extension encountered in the superficial...
  • New Philips Mobile Health Devices Hit the Market

    The medical-grade health monitoring devices connect to Philips’s HealthSuite Health App and cloud-based analytics. Chris NewmarkerPhilips devices hitting the market on August 1 include (clockwise from top left) a health watch, eart thermometer, upper arm blood pressure analyzer, and body analysis scale. (Images courtesy of Philips)Royal Philips on Monday announced worldwide availability of a host of health monitoring devices as the Dutch multinational continues to make a major push to expand in...
  • Google's Verily Bets Big on Bioelectronics

    Verily and GlaxoSmithKline plan to spend up to $712 million over the next seven years on a new U.K.-based venture called Galvani Bioelectronics. Chris Newmarker GlaxoSmithKline and Google's fellow Alphabet company Verily Life Sciences on Monday announced the formation of Galvani Bioelectronics, a new U.K.-headquartered company that will pioneer tiny bioelectronic devices to treat a wide range of chronic diseases.GSK will own a 55% equity interest in Galvani, and Verily will own 45%. An...
  • What Does Neurology Group's Recommendation on PFO Closure Mean for St. Jude?

     The American Academy of Neurology has recommended against percutaneous closure of a congenital heart defect in patients who have had a stroke just as St. Jude Medical anticipates a device to treat the condition will gain FDA approval.Nancy CrottiSt. Jude Medical doesn’t even have FDA approval yet for a device purported to prevent stroke, and a major physicians’ group is warning against implanting it in stroke survivors.Learn what it takes to innovate in the structural heart space at the...
  • Theranos CEO Courts Controversy at Clinical Chemistry Meeting

    Elizabeth Holmes will explain Theranos’s testing methodology at the American Association for Clinical Chemistry annual meeting, but some question the decision to give her a podium.Nancy CrottiThe founder and CEO of secretive and embattled Theranos is scheduled to discuss the science behind the company’s proprietary blood-testing technology at a prestigious clinical laboratory conference in Philadelphia on Monday.Network with your medtech colleagues at MD&M Minneapolis, September 21...
  • How Can OEMs Respond to the Threat of Medical Device Hacks?

    Wireless protocols and standards are urgently needed to protect medical devices from data infringement.Mike KanisCybersecurity is a critical issue for individuals, businesses, industries, and entire nations these days, and data vulnerability is alarmingly real. Breaches of every scale are reported in the news on a regular basis, usually tied to financial information stored by retailers and banks. The world is going digital in all aspects of modern life, from banking to social networking,...
  • EndoStim Inc.

         EndoStim Inc., based in St. Louis, MO, and The Hague, The Netherlands, has developed a laparoscopically implanted stimulation system that delivers electrical impulses to treat gastroesophageal reflux disease. In May, the company secured $25 million in venture funding that will help it conduct a pivotal U.S. clinical trial.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • OptiScan Biomedical Inc.

         OptiScan Biomedical’s OptiScanner 5000 bedside blood monitoring system automates monitoring of patients’ plasma glucose levels in the intensive care unit, and the company is expanding its platform to measure hemoglobin and central venous oxygen saturation levels. Monitoring these metrics can provide early warning when a critically ill patient’s condition goes downhill. The OptiScanner 5000 has been sold in Europe since 2014. OptiScan Biomedical nabbed $29.5 million in...
  • Sonendo Inc.

         Sonendo’s GentleWave System, which uses ultrasonic technology to make root canal procedures easier on patients, was a finalist in the 2016 Medical Design Excellence Awards. The Laguna Hills, CA-based company raked in $33.3 million from venture capitalists in Q2. Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • Mitralign Inc.

         Mitralign plays in the hot markets of transcatheter mitral and tricuspid valve repair. Its Mitralign Percutaneous Annuloplasty System (MPAS) received the CE Mark this past February for treatment of functional mitral regurgitation, and its Trialign system for treatment of functional tricuspid regurgitation is now enrolling patients in an early feasibility IDE study in the United States. The $39.8 million the Tewksbury, MA-based company brought in in venture capital last...
  • CVRx Inc.

         CVRx says its implantable Barostim System “triggers the body’s own natural blood flow regulation system” to treat high blood pressure and heart failure. The device has the CE Mark and may be sold in Europe but is limited to investigational use in the United States, although it has received Expedited Access Pathway from FDA. The Minneapolis-based company attracted $46.5 million in venture funding this past quarter.Continue >>Don't miss the MD&M Minneapolis...
  • Livongo Health

         Livongo Health’s program for diabetes management combines a connected glucometer with 24/7 support from certified diabetes educators who connect with users via phone, email, text, and mobile app. The Mountain View, CA-based company received a $49.5 million injection of venture capital in Q2. Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • TransMedics Inc.

         Transmedics is seeking to improve the process of transferring organs from donors to transplant patients, which typically involves a simple cooler and lots of room for error. The Andover, MA-based company’s Organ Care System provides a better way to maintain organs such as hearts, lungs, and livers outside the body through proprietary perfusion technology. Venture capitalists pumped in $51.2 million last quarter.Continue >>Don't miss the MD&M Minneapolis...
  • Earlens Corp.

         Earlens Corp.’s novel hearing aid uses a processor and light tip to convert sound to light, which is transmitted to a lens inside the ear that stimulates the users own hearing system. The result eliminates the annoying whistling sound that plagues traditional hearing aids. The Menlo Park, CA-based company brought in $53.6 million in venture capital last quarter.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image...